Maryland Department of Business and Economic Development

Pet Connect Business is a digital management system tailored for pet service providers. The company develops an application that simplifies the implementation and management of branded mobile apps and websites, allowing pet service providers to enhance their online presence. Its solutions enable these providers to acquire, support, and retain customers more effectively through an online management hub that facilitates updates and communication. By offering affordable and user-friendly digital tools, Pet Connect Business helps pet service providers strengthen their connections with clients and improve their overall service delivery.

Link Labs is a provider of an end-to-end Internet of Things (IoT) platform focused on tagging, locating, and monitoring equipment, supplies, and assets across various sectors, including construction, healthcare, logistics, manufacturing, and warehousing. Founded in 2014 by engineers from the Johns Hopkins University Applied Physics Lab, the company is headquartered in Annapolis, Maryland, and holds over 20 patents for its technological innovations. Link Labs is recognized for its flagship product, AirFinder, which allows for easy and effective asset management by integrating advanced intelligent radio-frequency identification and low-power IoT network technologies. This platform enables businesses to monitor and manage their assets in real-time, delivering both affordability and high performance while handling billions of IoT events each month.

Mobile System 7 is an enterprise security company founded by former Intelligence Community professionals, specializing in the protection of enterprise data from unauthorized access and cyber threats. The company's flagship product, Interlock, distinguishes itself from traditional security solutions by focusing not merely on securing endpoints, but on safeguarding access to critical data and services. By leveraging advanced analytics and real-time access controls, Interlock effectively monitors and protects valuable enterprise information. In addition to Interlock, Mobile System 7 also offers a data-driven Sentry platform designed to secure, deploy, and manage mobile devices within organizations, further enhancing its comprehensive approach to enterprise security.

TRX Systems is a developer of indoor location solutions that provide precise, infrastructure‑free tracking in environments where GPS is unavailable. Its flagship NEON platform includes a wearable sensor unit, software for real‑time mapping, and APIs that fuse data from Wi‑Fi, Bluetooth, GPS, and time‑of‑flight ranging to deliver accurate positioning for personnel and assets. The NEON Personnel Tracker is used by industrial, security, public‑safety, and defense customers, while the NEON Signal Mapper offers 3‑D location for indoor test and measurement. Sensors are embedded in mobile phones, radios, and industrial devices, enabling seamless integration across commercial and mission‑critical applications. Founded in 2001, the company is headquartered in Greenbelt, Maryland, and sells its products through online channels.

Zymetis is a biotechnology company founded in 2006 by Dr. Steve Hutcheson at the University of Maryland, focused on producing affordable next-generation transportation fuels. The company specializes in the development of ethanol and other biofuels derived from various plants and plant waste, utilizing innovative cellulosic sources. Zymetis leverages novel enzymes to enhance production processes, aiming to achieve lower costs while improving yields and efficiencies in biofuel production. Recognized for its contributions to green technology, Zymetis was named to the GoingGreen East 50 Top Company List in 2009, highlighting its role in advancing sustainable energy solutions.

ClassifEye produces a secure fingerprint authentication technology. ClassifEye has incorporated a comprehensive software solution, based on existing cell-phone cameras. This enables fast and easy deployment of identity management solutions for mobile markets at a fraction of the cost of comparative authentication techniques. No biometric sensors and no extra hardware are needed. A simple application download for existing phones makes ClassifEye's solution a winning step towards securing electronic transactions and increasing revenues.

My Ad Box attempts to create a process that would protect the privacy of classified advertisers while offering 24/7 contact for respondents to their ads. In June 2005, Stinnie and co-founder, Joe Hudson, launched My Ad Box - a dedicated, disposable phone number and email address that collects all responses related to an ad - without intruding on the rest of the advertiser's life. Customers can respond any time, while advertisers can store messages and retrieve them from one handy location - their My Ad Box account. MAB products are currently being sold by newspapers across the country, from the mid-Atlantic to Colorado, and even Canada. MAB's innovative concept has been covered nationally in television news reports and business publications. The system is easy to use, efficiently designed and an effective way to meet the demands of the modern classified customer while limiting the distractions, dead-ends and potential intrusions that can come from revealing direct personal information in an ad.

Innovative Biosensors' technology is built upon a foundation of a genetically engineered biosensor that allows for extremely rapid testing of analytes, providing high levels of sensitivity and specificity. The patented, self-contained biosensor system is capable of generating a sensitive and specific result with minimal amount of reagents in minutes, making it a cost-effective alternative to traditional laboratory testing. In addition, the biosensors can be engineered to detect one target or several targets of interest simultaneously and used to perform a wide variety of bioassays. Designed for real-time detection, minimally-skilled personnel can perform tests and analysis at the site of sampling using small, portable, space-saving instrumentation

NeuroNascent, Inc., founded in 2004 and based in Clarksville, Maryland, with additional facilities in Rockville and Walkersville, focuses on developing first-in-class, small-molecule therapeutics aimed at treating chronic neurodegenerative disorders and depression. The company's pipeline includes NNI-362 for Alzheimer's disease, NNI-351 for depression, PTSD, and Down syndrome, and NNI-370 for Parkinson's disease. Additionally, NeuroNascent is exploring the use of Arctic ground squirrel neural stem cells for conditions related to ischemia, tolerance, and hibernation.

Zenoss Inc. is a developer of IT operations and application monitoring solutions, headquartered in Austin, Texas, with an additional office in Coventry, United Kingdom. The company offers Zenoss Cloud, a software-as-a-service platform that normalizes machine data to prevent service disruptions across various IT environments. Its monitoring solutions provide comprehensive visibility into cloud, virtual, and physical infrastructures, assisting organizations in managing networks, servers, and storage. Zenoss aims to enhance IT service reliability by utilizing machine learning algorithms to predict and mitigate outages, thereby reducing downtime and operational costs. The company serves a range of industries, including federal, financial, and technology sectors, and has established strategic partnerships with notable firms such as Accenture, AWS, and Cisco. Zenoss was originally incorporated in 2005 as Zentinel, Inc.

Sirnaomics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing targeted therapeutics for significant human diseases using RNA interference (RNAi) technology. Founded in 2007 and headquartered in Gaithersburg, Maryland, with additional offices in Cambridge, Massachusetts, and facilities in Suzhou and Guangzhou, China, Sirnaomics is dedicated to addressing critical medical needs in oncology, anti-fibrotic therapeutics, and viral infections. The company's product portfolio includes several small interfering RNA (siRNA) therapeutics such as STP705 for scar reduction, STP909 for colon cancer, and STP900 for HPV and cervical cancer, among others. Sirnaomics employs proprietary Polypeptide Nano-Particle (PNP) technology to enhance drug delivery, allowing effective targeting of the tumor microenvironment and various cell types, particularly in the liver. Through its innovative approach, Sirnaomics aims to create impactful treatments for diseases with large market opportunities.

Three Stage Media, Inc. provides online media and marketing solutions for the tradeshow industry. The company focuses on developing online event portals that serve as an online show guide, search engine, and event-planning interface for attendees. It offers eventLeads for tradeshow registration process; eventAds for display media placements within show portals, show-floor kiosks, and e-newsletters; eventVideo that enables users to place custom streaming video news station on supplier microsite within the online event portal; eventMobile, which enables users to connect with on-site attendees; and eventMetrics for pre- and post-show performance reports. The company also provides eventPortal, an online show portal equipped with search engine, attendee event-planning interface, and comprehensive supplier directory; eventMarketing for lead generation, online advertising, search engine marketing, video advertising, and mobile marketing; and eventMetrics that provides data highlighting existing exhibitor performance and the opportunity afforded prospective exhibitors. It serves show organizers, exhibitors, and attendees. Three Stage Media, Inc. was formerly known as BDMetrics, Inc. and changed its name in January, 2009. The company was founded in 2001 and is headquartered in Baltimore, Maryland.

Zenoss Inc. is a developer of IT operations and application monitoring solutions, headquartered in Austin, Texas, with an additional office in Coventry, United Kingdom. The company offers Zenoss Cloud, a software-as-a-service platform that normalizes machine data to prevent service disruptions across various IT environments. Its monitoring solutions provide comprehensive visibility into cloud, virtual, and physical infrastructures, assisting organizations in managing networks, servers, and storage. Zenoss aims to enhance IT service reliability by utilizing machine learning algorithms to predict and mitigate outages, thereby reducing downtime and operational costs. The company serves a range of industries, including federal, financial, and technology sectors, and has established strategic partnerships with notable firms such as Accenture, AWS, and Cisco. Zenoss was originally incorporated in 2005 as Zentinel, Inc.

GlycoMimetics, Inc. is a clinical-stage biotechnology company dedicated to the discovery and development of innovative glycomimetic drugs aimed at addressing significant unmet medical needs associated with diseases influenced by carbohydrate biology. The company’s lead drug candidate, rivipansel, is a pan-selectin antagonist that has completed Phase III clinical trials for treating vaso-occlusive crises in sickle cell disease. Additionally, GlycoMimetics is developing uproleselan, an E-selectin inhibitor that is being tested in combination with chemotherapy for acute myeloid leukemia (AML) and in a Phase III trial for relapsed/refractory AML. The company also offers GMI-1359, which targets E-selectin and a chemokine receptor, having completed Phase I clinical trials, and is involved in developing other candidates, including GMI-1687 and Galectin-3. GlycoMimetics has established research collaborations, including an agreement with the National Cancer Institute and a partnership with Apollomics for the commercialization of uproleselan and GMI-1687. Founded in 2003, the company is headquartered in Rockville, Maryland.

Three Stage Media, Inc. provides online media and marketing solutions for the tradeshow industry. The company focuses on developing online event portals that serve as an online show guide, search engine, and event-planning interface for attendees. It offers eventLeads for tradeshow registration process; eventAds for display media placements within show portals, show-floor kiosks, and e-newsletters; eventVideo that enables users to place custom streaming video news station on supplier microsite within the online event portal; eventMobile, which enables users to connect with on-site attendees; and eventMetrics for pre- and post-show performance reports. The company also provides eventPortal, an online show portal equipped with search engine, attendee event-planning interface, and comprehensive supplier directory; eventMarketing for lead generation, online advertising, search engine marketing, video advertising, and mobile marketing; and eventMetrics that provides data highlighting existing exhibitor performance and the opportunity afforded prospective exhibitors. It serves show organizers, exhibitors, and attendees. Three Stage Media, Inc. was formerly known as BDMetrics, Inc. and changed its name in January, 2009. The company was founded in 2001 and is headquartered in Baltimore, Maryland.

Advanced BioNutrition Corp. is a company based in Columbia, Maryland, founded in 2001, that specializes in developing environmentally sustainable and science-based bioactive stabilization and delivery solutions. Its offerings include MicroMatrix targeted delivery systems, which stabilize and protect bioactives for various applications in human nutrition, health, agriculture, and food safety. The company focuses on functional ingredients aimed at enhancing animal health, particularly in aquaculture, and provides technologies that can be customized for diverse industries. With a portfolio of over 40 patents, Advanced BioNutrition continues to explore innovative verticals, enabling its clients to improve product development and performance across human, animal, and industrial applications. The company also offers opportunities for licensing and acquisition of its technologies.

GlycoMimetics, Inc. is a clinical-stage biotechnology company dedicated to the discovery and development of innovative glycomimetic drugs aimed at addressing significant unmet medical needs associated with diseases influenced by carbohydrate biology. The company’s lead drug candidate, rivipansel, is a pan-selectin antagonist that has completed Phase III clinical trials for treating vaso-occlusive crises in sickle cell disease. Additionally, GlycoMimetics is developing uproleselan, an E-selectin inhibitor that is being tested in combination with chemotherapy for acute myeloid leukemia (AML) and in a Phase III trial for relapsed/refractory AML. The company also offers GMI-1359, which targets E-selectin and a chemokine receptor, having completed Phase I clinical trials, and is involved in developing other candidates, including GMI-1687 and Galectin-3. GlycoMimetics has established research collaborations, including an agreement with the National Cancer Institute and a partnership with Apollomics for the commercialization of uproleselan and GMI-1687. Founded in 2003, the company is headquartered in Rockville, Maryland.

Viracor-IBT Laboratories is dedicated to being the leading specialty diagnostics laboratory partner in allergy, immunology, and infectious disease testing. They provide doctors and hospitals the tests, results and support they need to deliver the best care possible, and they collaborate with pharmaceutical researchers to solve difficult problems and accelerate drug development.

Bluefire Security develops security software for wireless and mobile handheld devices.

Three Stage Media, Inc. provides online media and marketing solutions for the tradeshow industry. The company focuses on developing online event portals that serve as an online show guide, search engine, and event-planning interface for attendees. It offers eventLeads for tradeshow registration process; eventAds for display media placements within show portals, show-floor kiosks, and e-newsletters; eventVideo that enables users to place custom streaming video news station on supplier microsite within the online event portal; eventMobile, which enables users to connect with on-site attendees; and eventMetrics for pre- and post-show performance reports. The company also provides eventPortal, an online show portal equipped with search engine, attendee event-planning interface, and comprehensive supplier directory; eventMarketing for lead generation, online advertising, search engine marketing, video advertising, and mobile marketing; and eventMetrics that provides data highlighting existing exhibitor performance and the opportunity afforded prospective exhibitors. It serves show organizers, exhibitors, and attendees. Three Stage Media, Inc. was formerly known as BDMetrics, Inc. and changed its name in January, 2009. The company was founded in 2001 and is headquartered in Baltimore, Maryland.

Panacos Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of small-molecule oral drugs aimed at treating human immunodeficiency virus (HIV) and other viral diseases. Established in 1999 and based in Watertown, Massachusetts, the company utilizes innovative technologies to target specific stages in the viral life cycle, such as virus maturation and fusion. Its product pipeline includes advanced programs centered on HIV maturation inhibition, representing the company's commitment to developing next-generation anti-infective therapies.

Qovia is a company that specializes in voice over Internet Protocol (VoIP) telephony monitoring and management technologies. Founded in 2002 and based in Frederick, Maryland, Qovia develops software products designed to monitor and manage voice quality on VoIP telephone systems. Its solutions cater to a diverse range of customers, including school districts, government agencies, law enforcement, banking and financial institutions, call centers, and voice carriers. By leveraging internet technology to enhance voice communication, Qovia positions itself at the forefront of next-generation phone systems.

Viracor-IBT Laboratories is dedicated to being the leading specialty diagnostics laboratory partner in allergy, immunology, and infectious disease testing. They provide doctors and hospitals the tests, results and support they need to deliver the best care possible, and they collaborate with pharmaceutical researchers to solve difficult problems and accelerate drug development.

Qovia is a company that specializes in voice over Internet Protocol (VoIP) telephony monitoring and management technologies. Founded in 2002 and based in Frederick, Maryland, Qovia develops software products designed to monitor and manage voice quality on VoIP telephone systems. Its solutions cater to a diverse range of customers, including school districts, government agencies, law enforcement, banking and financial institutions, call centers, and voice carriers. By leveraging internet technology to enhance voice communication, Qovia positions itself at the forefront of next-generation phone systems.

Vapotherm, Inc. is a medical technology company specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat patients of all ages experiencing respiratory distress. Headquartered in Exeter, New Hampshire, the company offers a range of precision flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through a small-bore nasal interface. Vapotherm also provides various companion products, such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air, and aerosol solutions for medication delivery. Additionally, the company offers disposable products, including single-use nasal interfaces and Oxygen Assist Modules to help clinicians maintain target oxygen levels. Vapotherm generates revenue primarily through direct sales to hospitals in the United States and through distributors in select international markets. Founded in 1993, the company is committed to enhancing clinical outcomes and improving the quality of life for patients.

Advanced BioNutrition Corp. is a company based in Columbia, Maryland, founded in 2001, that specializes in developing environmentally sustainable and science-based bioactive stabilization and delivery solutions. Its offerings include MicroMatrix targeted delivery systems, which stabilize and protect bioactives for various applications in human nutrition, health, agriculture, and food safety. The company focuses on functional ingredients aimed at enhancing animal health, particularly in aquaculture, and provides technologies that can be customized for diverse industries. With a portfolio of over 40 patents, Advanced BioNutrition continues to explore innovative verticals, enabling its clients to improve product development and performance across human, animal, and industrial applications. The company also offers opportunities for licensing and acquisition of its technologies.

Bluefire Security develops security software for wireless and mobile handheld devices.

Viracor-IBT Laboratories is dedicated to being the leading specialty diagnostics laboratory partner in allergy, immunology, and infectious disease testing. They provide doctors and hospitals the tests, results and support they need to deliver the best care possible, and they collaborate with pharmaceutical researchers to solve difficult problems and accelerate drug development.

Advanced BioNutrition Corp. is a company based in Columbia, Maryland, founded in 2001, that specializes in developing environmentally sustainable and science-based bioactive stabilization and delivery solutions. Its offerings include MicroMatrix targeted delivery systems, which stabilize and protect bioactives for various applications in human nutrition, health, agriculture, and food safety. The company focuses on functional ingredients aimed at enhancing animal health, particularly in aquaculture, and provides technologies that can be customized for diverse industries. With a portfolio of over 40 patents, Advanced BioNutrition continues to explore innovative verticals, enabling its clients to improve product development and performance across human, animal, and industrial applications. The company also offers opportunities for licensing and acquisition of its technologies.

Bluefire Security develops security software for wireless and mobile handheld devices.